Cargando…
Preoperative adjuvant transarterial chemoembolization cannot improve the long term outcome of radical therapies for hepatocellular carcinoma
Combinations of transarterial chemoembolization (TACE) and radical therapies (pretransplantation, resection and radiofrequency ablation) for hepatocellular carcinoma (HCC) have been reported as controversial issues in recent years. A consecutive sample of 1560 patients with Barcelona Clinic Liver Ca...
Autores principales: | Jianyong, Lei, Jinjing, Zhong, Lunan, Yan, Jingqiang, Zhu, Wentao, Wang, Yong, Zeng, Bo, Li, Tianfu, Wen, Jiaying, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290748/ https://www.ncbi.nlm.nih.gov/pubmed/28155861 http://dx.doi.org/10.1038/srep41624 |
Ejemplares similares
-
Response to transarterial chemoembolization may serve as selection criteria for hepatocellular carcinoma liver transplantation
por: Lei, Jianyong, et al.
Publicado: (2017) -
Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: Transarterial Chemoembolization or Hepatic Resection?
por: Jianyong, Lei, et al.
Publicado: (2014) -
Adjuvant transarterial chemoembolization to improve the prognosis of hepatocellular carcinoma following curative resection
por: Kuang, Xuejun, et al.
Publicado: (2018) -
Adjuvant transarterial chemoembolization timing after radical resection is an independent prognostic factor for patients with hepatocellular carcinoma
por: Sun, Hongfa, et al.
Publicado: (2023) -
Hepatocellular carcinoma cases with high levels of c-Raf-1 expression may benefit from postoperative adjuvant sorafenib after hepatic resection even with high risk of recurrence
por: Lei, Jianyong, et al.
Publicado: (2016)